You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has announced the appointment of its current Chairman Torbjørn Bjerke as its new Chief Executive Officer, effective as from the Annual General Meeting to be held on May 25. Torbjørn Bjerke succeeds Jeppe Øvlesen, who will remain a committed shareholder of the company. The NominatioAlready a subscriber Login…
Nanoform Finland will convene an extraordinary general meeting (EGM) on November 17 to elect Jeanne Thoma as a new board member. “Following the successful completion of our clinical trial and commercial expansion, we’ve reached an exciting point in Nanoform’s growth trajectory and are deligAlready a subscriber Login You have read…
Omnio has appointed Ulrika Norin, who has a long history of working with drug development startups, as its new CEO. “I am excited look forward to being a part of Omnio’s team. We have made significant progress in finding identifying ways to help difficulthard-to-treat heal patients with theirAlready a subscriber…
Immunicum has announced that Jeroen Rovers, M.D., Ph.D., has been appointed to the position of Chief Medical Officer (CMO). Rovers transitions from his role as Managing Director of DCprime and continues to serve on Immunicum’s management team. Peter Suenaert, M.D., Ph.D., current CMO of ImmunicAlready a subscriber Login You have…
